The early clinical and laboratory predictors of GBS outcome: hospital-based study, Assiut University, Upper Egypt

Table 5 Multiple ordinal and linear regression between baseline clinical rating scales and HDS and ONLS outcome after controlling for age and sex

HDS outcome/different rating scales	Estimate	Std. error	Wald	df	Sig.
MRC sum score at nadir	− 0.041	0.794	0.003	1	0.959
MRC sum score at onset	− 0.051	0.065	0.601	1	0.438
MRC sum score at 10th days after treatment	− 0.155	0.042	13.510	1	< 0.0001
EGRIS RISK onset	− 0.190	0.419	0.207	1	0.649
EGRIS RISK 10 days	− 0.172	0.427	0.161	1	0.688
Age	− 0.016	0.017	0.915	1	0.339
Sex	0.154	0.534	0.083	1	0.773

ONLS outcome/ different rating scales	Estimate	Std. error	Wald	df	Sig.
MRC sum score at nadir	− 0.337	1.013	− 0.116	− 0.332	0.741
MRC sum score at onset	− 0.016	0.083	− 0.066	− 0.189	0.851
MRC sum score at 10th days after treatment	− 0.136	0.047	− 0.581	− 2.904	0.005
EGRIS RISK onset	0.020	0.557	0.011	0.035	0.972
EGRIS RISK 10 days	− 0.026	0.537	− 0.014	− 0.048	0.962
Age	0.825	0.699	0.161	1.180	0.244
Sex	− 0.364	0.703	− 0.051	− 0.517	0.607

MRC Medical Research Council score, EGRIS Erasmus GBS respiratory insufficiency score, HDS Hughes Disability Scale